サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1679391

米国の創傷洗浄市場規模、シェア、動向分析レポート：製品別、製品形態別、用途別、最終用途別、およびセグメント予測、2025年～2030年

U.S. Wound Wash Market Size, Share & Trends Analysis Report By Product (Antiseptic, Saline Solution), By Product Form (Solutions, Sprays, Wipes), By Application (Acute Wounds, Chronic Wounds), By End-use, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
米国の創傷洗浄市場規模、シェア、動向分析レポート：製品別、製品形態別、用途別、最終用途別、およびセグメント予測、2025年～2030年
出版日: 2025年02月19日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の創傷洗浄市場の成長と動向

Grand View Research, Inc.の最新レポートによると、米国の創傷洗浄市場規模は2030年までに4億2,081万米ドルに達すると予測され、予測期間中にCAGR 5.56％で拡大すると予測されています。

米国の創傷洗浄市場は、外科手術や外傷症例の増加、糖尿病性潰瘍や褥瘡などの慢性創傷の有病率の上昇により、大きな成長を遂げています。従来の創傷洗浄方法は、抗菌剤、バイオフィルム破壊ソリューション、自動灌流システムの進歩によって進化し、創傷ケアをより効果的かつ効率的にしています。先進的抗菌ソリューションへのシフトは、創傷洗浄市場を牽引する最も重要な要因の一つです。

米国の創傷洗浄市場における新製品の上市とFDA承認は、技術革新の促進、安全基準の強化、臨床転帰の改善により、創傷洗浄と手術用洗浄の大きな進歩を促しています。2023年6月、Armis BiopharmaのVeriCyn Wound WashはFDAから510（k）認可を取得し、創傷ケアソリューションの重要な進歩を示しました。この承認は、創傷残屑除去の安全性と有効性の基準を満たすことを保証し、製品の信頼性と普及を高めるものです。この承認はまた、創傷・手術用洗浄剤における技術的進歩の継続を反映しており、革新的な抗菌剤や生物活性製剤の開発を促進しています。安全で効果的な創傷洗浄ソリューションへの需要が高まる中、このようなFDAの承認は市場拡大を促進し、患者の転帰を改善し、米国の創傷洗浄市場のさらなる技術革新を促します。

さらに、米国の創傷ケア市場は、戦略的提携やパートナーシップを通じた軍需部門や産業関係者からの投資増加の影響を大きく受けています。これらの要因が一体となって技術革新を促進し、製品開発を強化し、市場開拓を拡大し、成長を後押ししています。例えば、2024年1月、米国陸軍はミネソタ州の3Mに外傷性創傷、感染症、関連治癒プロセスの医療ソリューションを開発するための3,420万米ドルの契約を発注しました。これらのイニシアチブは、軍や民間の環境における爆風、火傷、銃創などの急性外傷のケアを強化することを目的としています。

米国の創傷洗浄市場レポートハイライト

  • 製品別では、創傷ケアにおける主要な懸念事項である感染予防の効果により、消毒薬セグメントが最大の売上シェアを占めています。
  • 製品形態別では、多用途性、使いやすさ、広範囲の創傷を洗浄する能力により、溶液セグメントが最大の収益シェアを占めています。
  • 用途別では、急性創傷セグメントが最大の売上シェアを占めています。急性創傷はより一般的であり、しばしば早急なケアを必要とするため、創傷洗浄製品の需要を牽引しています。
  • 最終用途別では、病院が最大の売上シェアを占め、市場を独占しています。病院は創傷洗浄剤の最大消費者です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の創傷洗浄市場の変数、動向、範囲

  • 市場系統の展望
    • 補助市場の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 米国の創傷洗浄市場分析ツール
    • 産業分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の創傷洗浄市場：製品別、推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷洗浄剤市場の製品変動分析
  • 米国の創傷洗浄剤市場規模と動向分析、製品別、2018～2030年
  • 防腐剤
    • ポビドンヨード
    • クロルヘキシジン
    • ポリヘキサニド（PHMB）
    • その他
  • 生理食塩水
  • 灌漑ソリューション
  • パルス洗浄システム
    • 使い捨て
    • 再利用可能
    • 半使い捨て
  • その他

第5章 米国の創傷洗浄市場：製品形態別、推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷洗浄剤市場の製品形態変動分析
  • 米国の創傷洗浄剤市場規模と動向分析、製品形態別、2018～2030年
  • ソリューション
  • スプレー
  • ワイプ
  • その他

第6章 米国の創傷洗浄市場：用途別、推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷洗浄市場の用途変動分析
  • 米国の創傷洗浄市場規模と動向分析、用途別、2018～2030年
  • 急性創傷
    • 外科的創傷と外傷
    • 火傷と裂傷
  • 慢性創傷
    • 糖尿病性足潰瘍
    • 褥瘡
    • 静脈性下肢潰瘍
    • その他の慢性創傷

第7章 米国の創傷洗浄市場：最終用途別、推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷洗浄市場の最終用途変動分析
  • 米国の創傷洗浄剤市場規模と動向分析、最終用途別、2018～2030年
  • 病院
  • 専門クリニック
  • 外来手術センター
  • 軍事・防衛
  • その他

第8章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • Atlantis Consumer Healthcare Inc.
    • Medline Industries, LP
    • B. Braun SE
    • Johnson & Johnson Consumer Inc.（Johnson & Johnson）
    • Zimmer Biomet
    • Urgo Medical North America（URGO Group）
    • Coloplast Corp（Coloplast Group）
    • Molnlycke Health Care AB
    • Cardinal Health
    • Armis Biopharma
    • Bravida Medical
    • Irrimax Corporation
    • BD
    • Sanara MedTech Inc.
    • Pure& Clean
    • Innovacyn, Inc.
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. U.S. Wound Wash Market, By Product, 2018 - 2030 (USD Million)
  • Table 4. U.S. Wound Wash Market, By Product Form, 2018 - 2030 (USD Million)
  • Table 5. U.S. Wound Wash Market, By Application, 2018 - 2030 (USD Million)
  • Table 6. U.S. Wound Wash Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7. Participant's Overview
  • Table 8. Financial Performance
  • Table 9. Product Benchmarking
  • Table 10. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Wash Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Wash Market, for Antiseptic, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Wound Wash Market, for Povidone Iodine, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Wound Wash Market, for Chlorhexidine, 2018 - 2030 (USD Million)
  • Fig. 17 U.S. Wound Wash Market, for Polyhexanide (PHMB), 2018 - 2030 (USD Million)
  • Fig. 18 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Wound Wash Market, for Saline Solution, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Wound Wash Market, for Irrigation Solution, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. Wound Wash Market, for Pulsed Lavage Systems, 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Wound Wash Market, for Disposable, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Wound Wash Market, for Reusable, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Wound Wash Market, for Semi Disposable, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Wound Wash Market, for Solutions, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Wound Wash Market, for Sprays, 2018 - 2030 (USD Million)
  • Fig. 28 U.S. Wound Wash Market, for Wipes, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. Wound Wash Market, for Acute Wounds, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. Wound Wash Market, for Surgical & Traumatic Wounds, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. Wound Wash Market, for Burns & Lacerations, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. Wound Wash Market, for Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. Wound Wash Market, for Diabetic Foot Ulcers, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Wound Wash Market, for Pressure Ulcers, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. Wound Wash Market, for Venous Leg Ulcers, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Wound Wash Market, for Other Chronic Wounds, 2018 - 2030 (USD Million)
  • Fig. 38 U.S. Wound Wash Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Wound Wash Market, for Specialty Clinics, 2018 - 2030 (USD Million)
  • Fig. 40 U.S. Wound Wash Market, for Ambulatory Surgery Centers, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. Wound Wash Market, for Military & Defense, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. Wound Wash Market, for Others, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-524-8

U.S. Wound Wash Market Growth & Trends:

The U.S. wound wash market size is anticipated to reach USD 420.81 million by 2030 and is anticipated to expand at a CAGR of 5.56% during the forecast period, according to a new report by Grand View Research, Inc. The U.S. wound wash market is experiencing significant growth due to the increasing number of surgical procedures, trauma cases, and the rising prevalence of chronic wounds such as diabetic ulcers and pressure sores. Traditional wound cleansing methods have evolved with advancements in antimicrobial agents, biofilm-disrupting solutions, and automated irrigation systems, making wound care more effective and efficient. The shift toward advanced antimicrobial solutions is one of the most essential factors driving the wound wash market.

New product launches and FDA approvals in the U.S. wound wash market drive significant wound and surgical wash advancements by promoting innovation, enhancing safety standards, and improving clinical outcomes. In June 2023, VeriCyn Wound Wash from Armis Biopharma obtained 510(k) clearance from the FDA, marking a significant advancement in wound care solutions. This regulatory approval enhances the credibility and adoption of the product, ensuring it meets safety and efficacy standards for wound debris removal. The approval also reflects ongoing technological advancements in wound and surgical washes, promoting the development of innovative, antimicrobial, and bioactive formulations. As demand for safe and effective wound cleansing solutions grows, such FDA approvals drive market expansion, improve patient outcomes, and encourage further innovations in the U.S. wound wash market.

Furthermore, the U.S. wound care market is significantly influenced by increased investments from military sectors and industry players through strategic collaborations and partnerships. These factors collectively drive innovation, enhance product development, and expand market reach, propelling growth. For instance, in January 2024, the U.S. Army has awarded Minnesota's 3M Company a USD 34.2-million contract to develop medical solutions for traumatic wounds, infection, and associated healing processes. These initiatives aim to enhance care for acute trauma cases such as blasts, burns, and gunshot wounds in military and civilian settings.

U.S. Wound Wash Market Report Highlights:

  • Based on product, the antiseptic segment dominate the market with the largest revenue share owing to their effectiveness in preventing infection, a primary concern in wound care.
  • Based on product form, the solutions segment dominate the market with the largest revenue share owing to their versatility, ease of use, and ability to clean a wide range of wounds.
  • Based on application, the acute wound segment dominate the market with the largest revenue share. Acute wounds, being more common and often requiring immediate care, drive the demand for wound wash products.
  • Based on end-use, the hospitals dominated the market with the largest revenue share owing to their high volume of patients and diverse wound care needs. Hospitals are the largest consumers of wound wash products.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Wash Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing number of surgical procedures
      • 3.2.1.2. Rising prevalence of chronic wounds
      • 3.2.1.3. Advancements in wound and surgical washes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory approvals & compliance costs
      • 3.2.2.2. Adverse events and complications associated with the use of wound wash
  • 3.3. U.S. Wound Wash Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Wash Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Wash Market Product Movement Analysis
  • 4.3. U.S. Wound Wash Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Antiseptic
    • 4.4.1. Antiseptic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Povidone Iodine
      • 4.4.2.1. Povidone Iodine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Chlorhexidine
      • 4.4.3.1. Chlorhexidine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Polyhexanide (PHMB)
      • 4.4.4.1. Polyhexanide (PHMB) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Saline Solution
    • 4.5.1. Saline Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Irrigation Solution
    • 4.6.1. Irrigation Solution Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Pulsed Lavage Systems
    • 4.7.1. Pulsed Lavage Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Semi Disposable
      • 4.7.4.1. Semi Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Wound Wash Market: Product Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Wash Market Product Form Movement Analysis
  • 5.3. U.S. Wound Wash Market Size & Trend Analysis, by Product Form, 2018 to 2030 (USD Million)
  • 5.4. Solutions
    • 5.4.1. Solutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Sprays
    • 5.5.1. Sprays Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Wipes
    • 5.6.1. Wipes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Wound Wash Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Wash Market Application Movement Analysis
  • 6.3. U.S. Wound Wash Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Acute Wounds
    • 6.4.1. Acute Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Surgical & Traumatic Wounds
      • 6.4.2.1. Surgical & Traumatic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Burns & Lacerations
      • 6.4.3.1. Burns & Lacerations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Chronic Wounds
    • 6.5.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Diabetic Foot Ulcers
      • 6.5.2.1. Diabetic Foot Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Pressure Ulcers
      • 6.5.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. Venous Leg Ulcers
      • 6.5.4.1. Venous Leg Ulcers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Other Chronic Wounds
      • 6.5.5.1. Other Chronic Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Wound Wash Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Wash Market End Use Movement Analysis
  • 7.3. U.S. Wound Wash Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Military & Defense
    • 7.7.1. Military & Defense Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Atlantis Consumer Healthcare Inc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Service Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Medline Industries, LP
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Service Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. B. Braun SE
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Service Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Johnson & Johnson Consumer Inc. (Johnson & Johnson)
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Service Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Zimmer Biomet
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Service Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Urgo Medical North America (URGO Group)
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Service Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Coloplast Corp (Coloplast Group)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Service Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Molnlycke Health Care AB
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Service Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Cardinal Health
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Service Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Armis Biopharma
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Service Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. Bravida Medical
      • 8.2.11.1. Company Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Service Benchmarking
      • 8.2.11.4. Strategic Initiatives
    • 8.2.12. Irrimax Corporation
      • 8.2.12.1. Company Overview
      • 8.2.12.2. Financial Performance
      • 8.2.12.3. Service Benchmarking
      • 8.2.12.4. Strategic Initiatives
    • 8.2.13. BD
      • 8.2.13.1. Company Overview
      • 8.2.13.2. Financial Performance
      • 8.2.13.3. Service Benchmarking
      • 8.2.13.4. Strategic Initiatives
    • 8.2.14. Sanara MedTech Inc.
      • 8.2.14.1. Company Overview
      • 8.2.14.2. Financial Performance
      • 8.2.14.3. Service Benchmarking
      • 8.2.14.4. Strategic Initiatives
    • 8.2.15. Pure&Clean
      • 8.2.15.1. Company Overview
      • 8.2.15.2. Financial Performance
      • 8.2.15.3. Service Benchmarking
      • 8.2.15.4. Strategic Initiatives
    • 8.2.16. Innovacyn, Inc.
      • 8.2.16.1. Company Overview
      • 8.2.16.2. Financial Performance
      • 8.2.16.3. Service Benchmarking
      • 8.2.16.4. Strategic Initiatives